Related Experiment Video
Updated: May 10, 2026
10:52
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
Published on: June 5, 2015
Strategies to generate induced pluripotent stem cells
Michael Hayes1, Nicholas Zavazava
1Zavazava Lab, VAMC Iowa City, Iowa City, IA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|June 13, 2013
Summary
Induced pluripotent stem cells (iPSCs) offer an ethical alternative to embryonic stem cells (ESCs). Recent advancements in reprogramming techniques, including non-integrative methods and small molecules, are improving efficiency for potential clinical applications.
Area of Science:
- Stem cell biology
- Cellular reprogramming
- Regenerative medicine
Background:
- Embryonic stem cells (ESCs) are valuable but ethically controversial due to embryo destruction.
- Induced pluripotent stem cells (iPSCs) were developed to bypass ethical concerns by reprogramming somatic cells.
- Early iPSC generation relied on viral transduction of four transcription factors (Yamanaka factors).
Purpose of the Study:
- To review and highlight advancements in iPSC generation techniques.
- To discuss strategies for improving the efficiency and safety of cellular reprogramming.
- To assess the progress towards clinical application of iPSCs.
Main Methods:
- Review of various reprogramming strategies, including integrative and non-integrative methods.
- Discussion of polycistronic cassettes, site-specific recombination (loxP, piggyBac), and non-integrating vectors (adenoviral, episomal).
- Exploration of nucleic acid-free reprogramming (mRNA, miRNA, cell-penetrating peptides) and small molecule enhancers (valproic acid, PD0325901).
Main Results:
- Numerous protocols have been developed to generate iPSCs, simplifying the process and reducing risks.
- Non-integrative methods and small molecule enhancers have significantly improved reprogramming efficiency.
- Despite progress, the reprogramming process remains inefficient for widespread clinical use.
Conclusions:
- Recent developments in iPSC technology are moving towards safer and more efficient reprogramming.
- Non-integrative techniques and small molecules are key to overcoming previous limitations.
- Further research is necessary to translate iPSC technology into safe and effective clinical therapies.
More Related Videos
08:14Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Published on: October 28, 2014
11:48Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System
Published on: November 13, 2009
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...